Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...

For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Many surgeons admit that medical robots can now operate with greater precision than human specialists. However, the complex ...

Roche believes it has exited phase 3 with data to support talks with regulatory agencies, but the mixed results raise ...

A one-time subretinal injection of Sura-vec at both high- and low-dose concentrations allowed more than half of patients with ...

Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the retina of mouse models. Neovascularization is a condition that is caused by age ...

TUESDAY, Oct. 21, 2025 (HealthDay News) — Scientists have restored partial vision to people with a common form of blindness ...